Enzyme replacement therapies: what is the best option?

BioImpacts : BI
Azam SafaryMohammad A Rafi

Abstract

Despite many beneficial outcomes of the conventional enzyme replacement therapy (ERT), several limitations such as the high-cost of the treatment and various inadvertent side effects including the occurrence of an immunological response against the infused enzyme and development of resistance to enzymes persist. These issues may limit the desired therapeutic outcomes of a majority of the lysosomal storage diseases (LSDs). Furthermore, the biodistribution of the recombinant enzymes into the target cells within the central nervous system (CNS), bone, cartilage, cornea, and heart still remain unresolved. All these shortcomings necessitate the development of more effective diagnosis and treatment modalities against LSDs. Taken all, maximizing the therapeutic response with minimal undesired side effects might be attainable by the development of targeted enzyme delivery systems (EDSs) as a promising alternative to the LSDs treatments, including different types of mucopolysaccharidoses ( MPSs ) as well as Fabry, Krabbe, Gaucher and Pompe diseases.

References

Nov 12, 2003·The Journal of Pharmacology and Experimental Therapeutics·Yunxiang ZhuSeng H Cheng
Jul 3, 2004·Nature Reviews. Molecular Cell Biology·Anthony H Futerman, Gerrit van Meer
Apr 26, 2006·The Tohoku Journal of Experimental Medicine·Hideyuki NakamaNorio Sakuragawa
May 22, 2008·Expert Opinion on Drug Delivery·Jaleh BararYadollah Omidi
Jan 13, 2010·Journal of Drug Targeting·William M Pardridge
Jan 30, 2010·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Silvia Muro
Sep 14, 2012·Annual Review of Genomics and Human Genetics·R J Desnick, E H Schuchman
Jan 9, 2013·Journal of Drug Targeting·Mostafa Heidari MajdYadollah Omidi
Feb 26, 2013·Colloids and Surfaces. B, Biointerfaces·Mostafa Heidari MajdYadollah Omidi
Jan 24, 2014·BioImpacts : BI·David A WengerMohammad A Rafi
May 3, 2014·International Journal of Nanomedicine·Efthymia-Iliana MatthaiouYadollah Omidi
Feb 11, 2015·Annual Review of Physiology·Haoxing Xu, Dejian Ren
Jul 16, 2015·Journal of Drug Targeting·Mohammad Johari-AharMohammad-Reza Rashidi
Oct 13, 2015·BioImpacts : BI·Jaleh Barar
Feb 11, 2016·Current Medicinal Chemistry·L Martín-BanderasM Fernández-Arévalo
Jan 1, 2015·BioImpacts : BI·Marzieh FathiYadollah Omidi
Jun 21, 2016·Expert Opinion on Drug Delivery·Roselena S SchuhHelder F Teixeira
Jun 25, 2016·BioImpacts : BI·Jaleh BararYadollah Omidi
Sep 21, 2016·Journal of Drug Targeting·Nazanin RahmanianYadollah Omidi
Nov 5, 2016·International Journal of Pharmaceutics·Vivienne H TamRodney D Priestley
Nov 18, 2016·BioImpacts : BI·Saeideh SameYadollah Omidi
Jan 4, 2017·PLoS Medicine·Matthew Herder
Jan 1, 2016·BioImpacts : BI·Jaleh BararYadollah Omidi
May 16, 2017·Advanced Drug Delivery Reviews·Melani Solomon, Silvia Muro
Nov 22, 2017·Molecular Therapy. Methods & Clinical Development·Steven Q LePatricia I Dickson
Feb 13, 2018·BioImpacts : BI·Marziyeh FathiYadollah Omidi
Mar 3, 2018·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Somayeh VandghanooniYadollah Omidi
May 31, 2018·Medicinal Research Reviews·Marziyeh FathiYadollah Omidi

❮ Previous
Next ❯

Citations

Jul 14, 2019·Journal of Biomolecular Structure & Dynamics·Majid SharifiMojtaba Falahati
Sep 4, 2019·Nature Reviews. Drug Discovery·Srinivasa Reddy BonamSylviane Muller
Jan 29, 2020·BioImpacts : BI·Marziyeh FathiJaleh Barar
Nov 7, 2019·Database : the Journal of Biological Databases and Curation·Sana AkhterGajendra P S Raghava
May 19, 2019·Cellular and Molecular Life Sciences : CMLS·Azam SafaryMohammad A Rafi
Sep 12, 2019·BioImpacts : BI·Mostafa Akbarzadeh KhiaviMohammad Hossein Somi
Sep 30, 2019·Cellular and Molecular Life Sciences : CMLS·Mostafa Akbarzadeh KhiaviYadollah Omidi
Dec 15, 2020·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Ibane AbasoloSimó Schwartz
Feb 2, 2021·Science Advances·Rachel S RileyMichael J Mitchell
Mar 4, 2021·Expert Opinion on Biological Therapy·Azam SafaryYadollah Omidi
Feb 23, 2021·Molecular Genetics and Metabolism Reports·Ashlee R StilesPriya S Kishnani
Oct 15, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jason Thomas DuskeyBarbara Ruozi
Oct 15, 2021·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Gemma L CarvillScott Demarest

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Clinical Pharmacology and Therapeutics
Volkmar Gieselmann
Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie
Vassili ValayannopoulosP de Lonlay
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Saida OrtolanoCarlos Spuch
© 2022 Meta ULC. All rights reserved